Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Clinicopathologic characteristics of ductal carcinoma in situ and risk of subsequent invasive breast cancer: a multicenter, population-based cohort study

Breast Cancer Research and Treatment(2025)10.1007/s10549-024-07599-xSource: DataRank Database

Clinicopathologic characteristics of ductal carcinoma in situ and risk of subsequent invasive breast cancer: a multicenter, population-based cohort study is a research paper published in Breast Cancer Research and Treatment (2025). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 2.25)OA: hybridTopics (71)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Yihong Wang ORCID,Fergus J. Couch ORCID,Heather Spencer Feigelson ORCID,Robert T. Greenlee ORCID,Stacey Honda ORCID

Live enrichment

PubMed:39832051 PMC:PMC11953078 OpenAlex:https://openalex.org/W4406617571

National Cancer Institute/National Institutes of Health

Grant: R01CA218429

Breast Cancer Research Foundation

Grant: BCRF-23-140

NCATS NIH HHS

Grant: UM1 TR004400

National Institutes of Health

Grant: 6R01CA218429-03

Molecular markers of risk of subsequent invasive breast cancer in women wth ductal carcinoma in situ

FWCI

2.25

Citation Percentile

0.9%

Citation Trend

2025

2026

hybridLicense: cc-by

journalhttps://link.springer.com/content/pdf/10.1007/s10549-024-07599-x.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s10549-024-07599-x.pdf

publisherhttps://link.springer.com/article/10.1007/s10549-024-07599-x/fulltext.html

journalhttps://doi.org/10.1007/s10549-024-07599-x

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39832051

Fields of Study

Breast Cancer Treatment StudiesBreast Lesions and CarcinomasCancer Risks and Factors03 medical and health sciences0302 clinical medicineHumansFemaleBreast NeoplasmsMiddle AgedCarcinoma, Intraductal, NoninfiltratingCase-Control StudiesAgedAdultRisk FactorsErb-b2 Receptor Tyrosine KinasesNeoplasm InvasivenessReceptors, EstrogenReceptors, ProgesteroneCohort StudiesNeoplasm Grading

MeSH Terms

AdultAgedBreast NeoplasmsCarcinoma, Intraductal, NoninfiltratingFemaleHumansMiddle AgedNeoplasm InvasivenessReceptors, EstrogenReceptors, ProgesteroneRisk FactorsCohort StudiesCase-Control StudiesCarcinoma, Ductal, BreastReceptor, ErbB-2Erb-b2 Receptor Tyrosine KinasesNeoplasm Grading

Keywords

MedicineBreast cancerDuctal carcinomaOncologyPopulationInternal medicineCancer registryMicrocalcificationMastectomyGynecologyEstrogen receptorCohort studyCohortCancerMammographyductal carcinoma in siturisk factorsInvasive Breast CancerClinicopathologicAdultResearchBreast NeoplasmsMiddle AgedErb-b2 Receptor Tyrosine KinasesCohort StudiesCarcinoma, Intraductal, NoninfiltratingReceptors, EstrogenCase-Control StudiesHumansFemaleNeoplasm InvasivenessNeoplasm GradingReceptors, ProgesteroneAged

Sustainable Development Goals

SDG 0: Good health and well-being